Annexin Pharmaceuticals AB (publ) (STO:ANNX)

STO:ANNX Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16.34	21.42	31.11	49.48	18.13
Cash & Short-Term Investments	16.34	21.42	31.11	49.48	18.13
Cash Growth	-23.71%	-31.17%	-37.12%	172.88%	325.33%
Other Receivables	0.42	2.63	1.86	1.02	0.28
Receivables	0.42	2.63	1.86	1.02	0.28
Inventory	-	-	-	-	4.28
Prepaid Expenses	0.63	0.87	0.67	0.22	0.2
Total Current Assets	17.38	24.92	33.65	50.72	22.9
Property, Plant & Equipment	1.08	1.17	1.26	1.35	1.44
Long-Term Investments	0.31	0.31	0.41	0.15	0.15
Other Intangible Assets	0.27	0.37	0.47	0.58	0.68
Other Long-Term Assets	-	-	0.89	-	-
Total Assets	19.04	26.76	36.68	52.79	25.16
Accounts Payable	2.96	4.33	3.33	3.51	2.9
Accrued Expenses	1.98	3.3	2.43	1.7	1.42
Other Current Liabilities	0.39	0.32	0.77	0.84	0.2
Total Current Liabilities	5.32	7.95	6.53	6.06	4.52
Total Liabilities	5.32	7.95	6.53	6.06	4.52
Common Stock	8.82	5.74	2.56	27.45	21.22
Additional Paid-In Capital	341.36	299.29	269.63	220.91	148.91
Retained Earnings	-336.46	-286.21	-242.16	-201.63	-149.49
Comprehensive Income & Other	-	-	0.12	-	-
Shareholders' Equity	13.71	18.81	30.15	46.73	20.64
Total Liabilities & Equity	19.04	26.76	36.68	52.79	25.16
Net Cash (Debt)	16.34	21.42	31.11	49.48	18.13
Net Cash Growth	-23.71%	-31.17%	-37.12%	172.88%	349.26%
Net Cash Per Share	0.04	0.13	0.21	0.60	0.29
Filing Date Shares Outstanding	532.98	346.58	154.5	137.24	70.73
Total Common Shares Outstanding	532.98	346.58	154.5	137.24	70.73
Working Capital	12.06	16.97	27.12	44.66	18.38
Book Value Per Share	0.03	0.05	0.20	0.34	0.29
Tangible Book Value	13.45	18.44	29.68	46.15	19.96
Tangible Book Value Per Share	0.03	0.05	0.19	0.34	0.28

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.